Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Identifying biomarker correlates associated with the development of hallucinations and delusions in Alzheimer's disease: A multimodal neuroimaging and genetic analysis study
EF 2017-18
Résumé
The co-occurrence of neuropsychiatric symptoms and Alzheimer’s disease (AD) represents a devastating phenotype (AD+P) that affects close to 50% of individuals with AD. Psychotic symptoms in AD can be divided into two major subgroups: delusions and hallucinations. Research has shown that AD+P is characterized by accelerated progression of disease, rapid functional decline and higher rates of institutionalization. It is therefore important to identify the biomarker correlates associated with the development of specific psychotic symptoms, as this will help to inform the development of targeted treatment approaches and may aid in identifying presymptomatic patients that may be prone to developing psychotic symptoms with AD.
Previous research has examined whether atrophy in specific brain regions may give rise to psychotic symptoms; however, the results to date have been inconsistent because small sample sizes have limited the focus of prior studies to a subset of biomarkers. The proposed study will include a large cohort of AD patients and as such will be one of the first studies powered to investigate the interaction between neuroanatomical and genetic risk factors in AD+P.
The objective of this study is to use a multimodal approach that incorporates magnetic resonance imaging, positron emission tomography and genome-wide analysis to determine the relationship between the frequency and severity of neuropsychiatric symptoms in AD and changes in regional brain volume, glucose metabolism, and genetic polymorphisms with known functional consequences in neurotransmitter systems. This is critical for informing the development of novel and specific therapeutic targets for these symptoms in AD and other neurodegenerative diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
403461
Name
Ahmed Juweiriya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying biomarker correlates associated with the development of hallucinations and delusions in Alzheimer's disease: A multimodal neuroimaging and genetic analysis study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Alzheimer'S Disease; Delusions; Dementia; Genetics; Hallucinations; Magnetic Resonance Imaging; Neuropathology; Positron Emission Tomography; Psychosis
Abstract
The co-occurrence of neuropsychiatric symptoms and Alzheimer’s disease (AD) represents a devastating phenotype (AD+P) that affects close to 50% of individuals with AD. Psychotic symptoms in AD can be divided into two major subgroups: delusions and hallucinations. Research has shown that AD+P is characterized by accelerated progression of disease, rapid functional decline and higher rates of institutionalization. It is therefore important to identify the biomarker correlates associated with the development of specific psychotic symptoms, as this will help to inform the development of targeted treatment approaches and may aid in identifying presymptomatic patients that may be prone to developing psychotic symptoms with AD.
Previous research has examined whether atrophy in specific brain regions may give rise to psychotic symptoms; however, the results to date have been inconsistent because small sample sizes have limited the focus of prior studies to a subset of biomarkers. The proposed study will include a large cohort of AD patients and as such will be one of the first studies powered to investigate the interaction between neuroanatomical and genetic risk factors in AD+P.
The objective of this study is to use a multimodal approach that incorporates magnetic resonance imaging, positron emission tomography and genome-wide analysis to determine the relationship between the frequency and severity of neuropsychiatric symptoms in AD and changes in regional brain volume, glucose metabolism, and genetic polymorphisms with known functional consequences in neurotransmitter systems. This is critical for informing the development of novel and specific therapeutic targets for these symptoms in AD and other neurodegenerative diseases.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Juweiriya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~